Vuzix Corp
Business
Vuzix Corporation designs and manufactures AI-enabled smart glasses and augmented reality display technologies for enterprise, medical, defense, and security applications. The company offers near-eye displays, heads-up displays, and wearable computing devices, along with waveguide optics and display engines for third-party OEM and ODM partners. Primary business segments include Vuzix-branded smart glasses models, software solutions through subsidiary Moviynt, and engineering services to integrators. The company sells globally through direct sales, resellers, and distributors.
Summary from 10-K filed 2026-03-12
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Total Sales | 6 | 6 | 12 | 12 | 13 | |
| Cost of Sales - Depreciation and Amortization | 677,931 | 734,456 | 886,117 | 799,317 | 1 | |
| Total Cost of Sales | 7 | 11 | 15 | 10 | 12 | |
| Gross Loss | −1 | −6 | −3 | 1 | 2 | |
| Research and Development | 13 | 10 | 12 | 13 | 12 | |
| Selling and Marketing | 5 | 8 | 13 | 8 | 6 | |
| General and Administrative | 12 | 17 | 19 | 21 | 23 | |
| Depreciation and Amortization | 2 | 3 | 4 | 2 | 988,104 | |
| Loss on Goodwill and Other Intangible Asset Impairment | — | — | 2 | — | — | |
| Loss on Fixed Asset Disposal | 106,898 | 27,654 | 0 | 35,350 | 183,614 | |
| Impairment on Intangible Asset and Equity Investment | — | 30 | — | — | — | |
| Impairment of Patents and Trademarks | 0 | 0 | 41,869 | 97,675 | 80,163 | |
| Total Operating Expenses | 31 | 68 | 50 | 44 | 42 | |
| Loss From Operations | −33 | −74 | −52 | −42 | −40 | |
| Investment Income | 672,276 | 591,319 | 2 | 1 | 53,511 | |
| Other Taxes | 23,054 | 59,335 | −230,973 | −212,997 | — | |
| Foreign Exchange Loss | −60,564 | −217,317 | −44,062 | −180,589 | −143,196 | |
| Impairment Loss on Equity Investment | −400,000 | 0 | 0 | — | — | |
| Utility Improvement Refund | — | — | 208,271 | — | — | |
| Total Other Income, Net | 234,766 | 433,337 | 2 | 1 | −397,053 | |
| Loss Before Provision for Income Taxes | −32 | −74 | −50 | −41 | −40 | |
| Provision for Income Taxes | 0 | 0 | 0 | — | — | |
| Preferred Stock Dividends | −62,333 | — | — | — | — | |
| Loss Attributable to Common Shareholders - Basic | −32 | −74 | −50 | −41 | −40 | |
| Loss Attributable to Common Shareholders - Diluted | −32 | −74 | −50 | — | — | |
| Basic Net Loss per Common Share | −0.42 | −1.08 | −0.79 | −0.64 | −0.66 | |
| Diluted Net Loss per Common Share | −0.42 | −1.08 | −0.79 | −0.64 | −0.66 | |
| Weighted-average Shares Outstanding - Basic | 78 | 68 | 63 | 64 | 61 | |
| Weighted-average Shares Outstanding - Diluted | 78 | 68 | 63 | 64 | 61 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2025 2025-09-30 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 |
|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | 21 | — | 18 | 27 | 73 | |
| Accounts Receivable, net of allowance for credit losses of $46,000 at December 31, 2025 and $89,000 at December 31, 2024 | 2 | — | 2 | 4 | 4 | |
| Accrued Revenues in Excess of Billings | 533,665 | — | 673,498 | 165,771 | 269,129 | |
| Other Receivables | 379,615 | — | — | — | — | |
| Inventories, Net | 2 | — | 5 | 9 | 11 | |
| Manufacturing Vendor Prepayments | 256,090 | — | 372,081 | 403,801 | 998,671 | |
| Prepaid Expenses and Other Assets | 1 | — | 1 | 1 | 2 | |
| Total Current Assets | 27 | — | 27 | 42 | 91 | |
| Fixed Assets, Net | 8 | — | 8 | 8 | 4 | |
| Operating Lease Right-of-Use Assets, Net | 1 | 1 | 494,236 | 301,185 | 956,165 | |
| Patents and Trademarks, Net | 3 | — | 3 | 3 | 2 | |
| Technology Licenses, Net | 559,973 | — | 761,043 | 27 | 30 | |
| Other Assets, Net | 327,778 | — | 844,445 | 1 | 950,000 | |
| Total Assets | 40 | — | 39 | 86 | 131 | |
| Accounts Payable | 685,010 | — | 538,221 | 2 | 1 | |
| Unearned Revenue | 62,361 | — | 125,901 | 18,839 | 29,064 | |
| Accrued Expenses | 4 | — | 945,752 | 2 | 2 | |
| Other Taxes Payable | 49,513 | — | 8,163 | 46,727 | 214,997 | |
| Operating Lease Right-of-Use Liabilities | 500,911 | — | 494,236 | 163,513 | 651,011 | |
| Total Current Liabilities | 5 | — | 2 | 5 | 15 | |
| Operating Lease Right-of-Use Liability | 502,114 | — | — | 137,672 | 305,154 | |
| Total Liabilities | 5 | — | 2 | 5 | 16 | |
| Preferred Stock - $0.001 Par Value, 5,000,000 Shares Authorized; 419,959 and zero Shares of Series B Preferred Stock Issued and Outstanding as of December 31, 2025 and December 31, 2024 | 10 | — | — | — | — | |
| Common Stock - $0.001 Par Value, 200,000,000 shares authorized; 81,679,367 shares issued and 81,099,695 shares outstanding as of December 31, 2025 and 100,000,000 shares authorized; 76,553,694 shares issued and 75,974,022 shares outstanding as of December 31, 2024 | 81,680 | — | 76,553 | 65,304 | 63,783 | |
| Additional Paid-in Capital | 427 | — | 407 | 377 | 361 | |
| Accumulated Deficit | −400 | — | −368 | −294 | −244 | |
| Treasury Stock, at cost, 579,672 shares as of December 31, 2025 and December 31, 2024 | −2 | — | −2 | −2 | −2 | |
| Total Stockholders' Equity | 25 | — | 37 | 81 | 115 | |
| Total Liabilities, Mezzanine Equity, and Stockholders' Equity | 40 | — | 39 | 86 | 131 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Net Loss | −32 | −74 | −50 | −41 | −40 | |
| Depreciation and Amortization | 3 | 4 | 5 | 3 | 2 | |
| Stock-Based Compensation | 5 | 12 | 13 | 16 | 17 | |
| Allowance for Credit Losses | — | 977,363 | 2 | — | — | |
| Inventory Reserves for Obsolescence | 503,400 | 4 | 4 | 290,405 | 519,950 | |
| Impairment on Goodwill, Intangible Assets, and Equity Investments | 400,000 | 30 | 2 | — | — | |
| Accounts Receivable | −17,917 | 1 | −2 | −1 | −853,547 | |
| Accrued Revenues in Excess of Billings | 139,833 | −507,727 | 103,358 | −269,129 | — | |
| Other Receivables | −379,615 | 208,271 | 258,434 | — | — | |
| Inventories | 2 | 19,287 | −2 | 593,608 | −7 | |
| Manufacturing Vendor Prepayments | 115,991 | 31,720 | 594,870 | −494,620 | −19,019 | |
| Prepaid Expenses and Other Assets | 7,702 | 271,399 | 167,837 | −95,244 | −526,825 | |
| Accounts Payable | 146,789 | −1 | 358,883 | −843,015 | 537,607 | |
| Accrued Expenses | 2 | −1 | 745,904 | 251,231 | 436,276 | |
| Unearned Revenue | −63,540 | 107,062 | −10,225 | 1,268 | −13,355 | |
| Income and Other Taxes Payable | 41,350 | −38,564 | −168,270 | 94,755 | 10,589 | |
| Net Cash Flows Used in Operating Activities | −19 | −24 | −26 | −25 | −27 | |
| Purchases of Fixed Assets | −2 | −1 | −5 | −2 | −4 | |
| Investments in Patents and Trademarks | −554,816 | −560,958 | −632,483 | −499,031 | −593,184 | |
| Investments in Licenses | — | −1 | −11 | −17 | — | |
| Investments in Software Development | — | — | −125,000 | −125,000 | −250,000 | |
| Investment in Atomistic | — | — | −3 | — | — | |
| Investments in Other Equity Assets | −50,000 | — | −200,000 | −17 | −200,000 | |
| Net Cash Flows Used in Investing Activities | −3 | −3 | −19 | −21 | −5 | |
| Proceeds from Sale of Preferred and Common Stock to Quanta | 10 | 10 | — | — | — | |
| Proceeds from Exercise of Stock Options | 106,843 | 110,760 | 21,196 | 57,712 | 782,277 | |
| Proceeds from ATM Program, Net | 14 | 8 | — | — | 92 | |
| Purchase of Treasury Stock | — | — | −470,757 | −2 | — | |
| Net Cash Flows Provided by (Used in) Financing Activities | 24 | 18 | −449,561 | −2 | 116 | |
| Net Increase (Decrease) in Cash and Cash Equivalents | 3 | −8 | −46 | −48 | 84 | |
| Non-Cash Investment in Licenses | — | — | 1 | 12 | 1 | |
| Investment in Atomistic - Equity issued | — | 181,675 | 3 | — | — | |
| Accrued Preferred Dividends included in Accrued Expenses | 39,923 | — | — | — | — | |
| Depreciation and Amortization included in Research and Development Expense | 869,361 | 201,070 | 201,147 | — | — | |
| Stock-Based Compensation Expense - Expensed less Previously Issued | — | — | 92,454 | 61,824 | −1 | |
| Purchases of Fixed Assets included in Accrued Expenses | 723,023 | — | — | — | — |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is Vuzix Corp's CIK number?
Vuzix Corp's SEC CIK number is 0001463972 (1463972). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find Vuzix Corp's SEC filings?
All of Vuzix Corp's EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.
When did Vuzix Corp last report earnings?
Vuzix Corp (VUZI) most recently filed an earnings 8-K with the SEC on May 15, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001104659-26-062752). This is Vuzix Corp's most recent earnings filing of record — not a forecast of its next earnings date.
What is Vuzix Corp's most recent earnings 8-K?
Vuzix Corp's latest earnings 8-K (Item 2.02) was filed May 15, 2026 under accession 0001104659-26-062752. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.
View Vuzix Corp's latest earnings 8-K →
Look up any company's CIK number →